ADVFN ADVFN

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Caratteristiche principali

Icon for default Registrati gratuitamente per ottenere quotazioni in tempo reale, grafici interattivi, flusso di opzioni in tempo reale e altro ancora.
Aclaris Therapeutics Inc

Aclaris Therapeutics Inc (ACRS)

4,50
0,08
(1,81%)
Chiuso 22 Giugno 10:00PM
4,22
-0,28
(-6,22%)
Dopo le ore di negoziazione: 1:00AM

Aclaris Therapeutics Inc (ACRS) Operazioni degli insider

-
Filtra per:
Data Nome del titolare Azioni transazionate Intervallo di valore ($) Tipo di transazione Intervallo di prezzo ($) Azioni a fine dichiarazione % di variazione
2026-06-05Dr. Andrew Newman SchiffIndependent Director11,58k0,00Derivative Exercise and Retained Stock-25,54k82,95%
2026-06-05Dr. Maxine GowenIndependent Director11,58k0,00Derivative Exercise and Retained Stock-33,33k53,23%
2026-06-05Mr. Christopher P. MolineauxLead Independent Director11,58k0,00Derivative Exercise and Retained Stock-69,54k19,98%
2026-06-05Mr. William D. HumphriesIndependent Director11,58k0,00Derivative Exercise and Retained Stock-45,11k34,54%
2026-06-05Mr. Vincent J. MilanoIndependent Director11,58k0,00Derivative Exercise and Retained Stock-28,90k66,87%
2026-06-05Dr. Anand MehraIndependent Director11,58k0,00Derivative Exercise and Retained Stock-726,40k1,62%
2026-05-01Dr. Jesse W. HallChief Medical Officer-9,33k41,15kDerivative Exercise and Sale4,4127,05k-
2026-05-01Dr. Jesse W. HallChief Medical Officer27,05k0,00Derivative Exercise and Retained Stock-27,05k-
2026-04-23BML Capital Management, LLCSocietà-300,00k1,36MVendita4,5313,95M-2,11%
2026-03-01Mr. Kevin BalthaserCFO1,70k0,00Derivative Exercise and Retained Stock-187,45k0,91%
2026-03-01Mr. Kevin BalthaserCFO-677,001,94kDerivative Exercise and Sale2,87187,45k-
2026-02-03Mr. James LoeropChief Business Officer14,94k0,00Derivative Exercise and Retained Stock-192,26k8,42%
2026-02-03Mr. James LoeropChief Business Officer-5,94k20,60kDerivative Exercise and Sale3,47192,26k-
2026-02-03Dr. Neal S. WalkerCo-Founder, CEO & Chairman44,86k0,00Derivative Exercise and Retained Stock-1,54M2,99%
2026-02-03Dr. Neal S. WalkerCo-Founder, CEO & Chairman-18,61k64,58kDerivative Exercise and Sale3,471,54M-
2026-02-03Dr. Hugh M. DavisPresident, COO & Director18,68k0,00Derivative Exercise and Retained Stock-45,43k69,81%
2026-02-03Mr. Kevin BalthaserCFO15,58k0,00Derivative Exercise and Retained Stock-185,76k9,15%
2026-02-03Mr. Kevin BalthaserCFO-6,45k22,38kDerivative Exercise and Sale3,47185,76k-
2026-02-01Mr. James LoeropChief Business Officer22,81k0,00Derivative Exercise and Retained Stock-177,32k14,77%
2026-02-01Mr. James LoeropChief Business Officer-10,69k37,51kDerivative Exercise and Sale3,51177,32k-
2026-02-01Mr. Kevin BalthaserCFO9,77k0,00Derivative Exercise and Retained Stock-170,18k6,09%
2026-02-01Mr. Kevin BalthaserCFO-4,98k17,49kDerivative Exercise and Sale3,51170,18k-
2026-01-02Dr. Neal S. WalkerCo-Founder, CEO & Chairman19,20k0,00Derivative Exercise and Retained Stock-1,50M1,30%
2026-01-02Dr. Neal S. WalkerCo-Founder, CEO & Chairman-9,95k28,66kDerivative Exercise and Sale2,881,50M-
2025-12-31Mr. James LoeropChief Business Officer51,74k0,00Derivative Exercise and Retained Stock-155,04k50,08%
2025-12-31Mr. James LoeropChief Business Officer-40,17k120,09kDerivative Exercise and Sale2,88 - 3,01155,04k-
2025-12-31Mr. Kevin BalthaserCFO67,81k0,00Derivative Exercise and Retained Stock-160,41k73,22%
2025-12-31Mr. Kevin BalthaserCFO-26,65k79,62kDerivative Exercise and Sale2,88 - 3,01160,41k-
2025-12-02Dr. Hugh M. DavisPresident, COO & Director26,75k0,00Derivative Exercise and Retained Stock-26,75k-